The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Previous Investigations Other Litigations Cold Eeze Lawsuit Research Center

Zinc Gluconate Glycine

in this section: Zinc Gluconate Glycine | Types | Side Effects


Bookmark This Page Print This Page Email This Page

Cold EEZE Lawsuit Research: Learn More about Zinc Gluconate Glycine

Zinc gluconate glycine (sold as Cold EEZE by The Quigley Corporation) is a chemical derivative formed by adding the amino acid glycine to a compound of zinc gluconate. It is available as an over-the-counter remedy for the common cold.

Zinc gluconate, when made into a lozenge by itself, has a mildly acidic taste, which will turn into a bitter taste over a period of time. The addition of large amounts of glycine to the lozenge produces a much milder and more stable taste. The resulting commercial products have a nearly unlimited shelf life.

This compound was patented in 1985 by The Quigley Corporation, which has trademarked the name ZIGG™ for the compound. The company is also the only major supplier of zinc gluconate glycine, distributed under the brand name Cold-Eeze. All clinical studies of the compound to date have involved the lozenges in this product family.

Like its base compound zinc gluconate, zinc gluconate glycine has been shown in clinical trials to shorten the mean and median duration of symptoms of the common cold. The amount of glycine added can range anywhere from two to twenty moles of glycine for each mole of zinc gluconate (US Patent 4,684,528, Claim 1). The addition of glycine significantly reduces the effectiveness of the base compound, roughly proportional to the ratio of glycine to zinc gluconate.

The manufacturer claims that their product reduces the duration of common cold symptoms by 42%, compared to the natural duration. However, as stated above, the actual benefits gained from the product depends heavily on the amount of glycine added. Repeated clinical trials of the compound have generally shown a measurable, but varied, benefit relative to a placebo, typically on the order of a one to four day reduction in symptom duration.

©

Weitz & Luxenberg is no longer accepting Cold-EEZE cases.


see also:

Types Types of Cold EEZE Products: Info from Cold EEZE Lawyer/Attorneys
Types of Cold EEZE Products: Lawsuit Research from Cold EEZE Lawyers

Zinc Gluconate Glycine Cold EEZE Lawsuit Reseach Center from Cold EEZE Lawyer/Attorneys
Zinc Gluconate Glycine Info: Lawsuit Research from Cold EEZE Lawyers

Learn More Cold EEZE Lawsuit Reseach Center from Cold EEZE Lawyer/Attorneys
Learn More about Cold EEZE: Lawsuit Research from Cold EEZE Lawyers

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims